Safety of etanercept therapy in a patient with psoriasis, Down's syndrome and concomitant hepatitis C virus infection

被引：10

作者：

Alcaide, A. J. ^{[1
]}

Barrera, M. V. ^{[1
]}

Habicheyn, S. ^{[1
]}

Lopez, N. ^{[1
]}

Mendiola, M. V. ^{[1
]}

Herrera, E. ^{[1
]}

机构：

[1] Virgen Victoria Univ Hosp, Sch Med, Dept Dermatol, Malaga 29010, Spain

来源：

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2008年 / 22卷 / 12期

关键词：

D O I：

10.1111/j.1468-3083.2008.02693.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页数：3

共 6 条

[1] Etanercept therapy in two patients with psoriasis and concomitant hepatitis C [J].

De Simone, Clara ;

Paradisi, Andrea ;

Capizzi, Rodolfo ;

Carbone, Angelo ;

Siciliano, Massimo ;

Amerio, Pier Luigi ;

Gemelli, Policlinico A. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (06) :1102-1104

[2]

Khanna M, 2003, J Dermatolog Treat, V14, P229, DOI 10.1080/09546630310020470

[3] Etanercept therapy for patients with psoriatic arthritis and concurrent hepatitis C virus infection: Report of 3 cases [J].

Magliocco, MA ;

Gottlieb, AB .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 51 (04) :580-584

[4] Etanercept treatment for three months is safe in patients with rheumatological manifestations associated with hepatitis C virus [J].

Marotte, H. ;

Fontanges, E. ;

Bailly, F. ;

Zoulim, F. ;

Trepo, C. ;

Miossec, P. .

RHEUMATOLOGY, 2007, 46 (01) :97-99

[5] Etanercept monotherapy for a patient with psoriasis, psoriatic arthritis, and concomitant hepatitis C infection [J].

Rokhsar, C ;

Rabhan, N ;

Cohen, SR .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (02) :361-362

[6] Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study [J].

Zein, NN .

JOURNAL OF HEPATOLOGY, 2005, 42 (03) :315-322

← 1 →